Convergent impact of vaccination and antibiotic pressures on pneumococcal populations.


Journal

Cell chemical biology
ISSN: 2451-9448
Titre abrégé: Cell Chem Biol
Pays: United States
ID NLM: 101676030

Informations de publication

Date de publication:
15 Feb 2024
Historique:
received: 10 04 2023
revised: 08 09 2023
accepted: 07 11 2023
medline: 19 2 2024
pubmed: 6 12 2023
entrez: 5 12 2023
Statut: ppublish

Résumé

Streptococcus pneumoniae is a remarkably adaptable and successful human pathogen, playing dual roles of both asymptomatic carriage in the nasopharynx and invasive disease including pneumonia, bacteremia, and meningitis. Efficacious vaccines and effective antibiotic therapies are critical to mitigating morbidity and mortality. However, clinical interventions can be rapidly circumvented by the pneumococcus by its inherent proclivity for genetic exchange. This leads to an underappreciated interplay between vaccine and antibiotic pressures on pneumococcal populations. Circulating populations have undergone dramatic shifts due to the introduction of capsule-based vaccines of increasing valency imparting strong selective pressures. These alterations in population structure have concurrent consequences on the frequency of antibiotic resistance profiles in the population. This review will discuss the interactions of these two selective forces. Understanding and forecasting the drivers of antibiotic resistance and capsule switching are of critical importance for public health, particularly for such a genetically promiscuous pathogen as S. pneumoniae.

Identifiants

pubmed: 38052216
pii: S2451-9456(23)00390-2
doi: 10.1016/j.chembiol.2023.11.003
pmc: PMC10938186
mid: NIHMS1972974
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Pneumococcal Vaccines 0
Vaccines, Conjugate 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

195-206

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI168214
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI158076
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI165426
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI128756
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI172796
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI171038
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1075-1080
pubmed: 28096340
Science. 2012 Mar 16;335(6074):1376-80
pubmed: 22383809
Epidemics. 2010 Jun;2(2):80-4
pubmed: 21031138
BMC Microbiol. 2012 Jan 18;12:12
pubmed: 22251616
Antimicrob Agents Chemother. 2006 Oct;50(10):3361-6
pubmed: 17005818
Int J Infect Dis. 2010 Mar;14(3):e197-209
pubmed: 19700359
Lancet Glob Health. 2019 Jan;7(1):e58-e67
pubmed: 30554762
J Bacteriol. 2004 Jul;186(13):4395-8
pubmed: 15205444
Microb Genom. 2020 May;6(5):
pubmed: 32375991
Diagn Microbiol Infect Dis. 2010 Nov;68(3):334-6
pubmed: 20955919
J Infect. 2017 Aug;75(2):95-103
pubmed: 28579305
J Exp Med. 1945 Nov 30;82(6):445-65
pubmed: 19871511
J Exp Med. 1957 Aug 1;106(2):247-59
pubmed: 13449235
FEMS Microbiol Lett. 1995 Mar 1;126(3):299-303
pubmed: 7729674
Expert Rev Vaccines. 2017 Dec;16(12):1181-1190
pubmed: 29130395
J Infect Dis. 2023 Mar 1;227(5):610-621
pubmed: 36130327
Antimicrob Agents Chemother. 2015;59(6):3529-40
pubmed: 25845880
ISME J. 2021 May;15(5):1523-1538
pubmed: 33408365
Sci Rep. 2017 Feb 16;7:42808
pubmed: 28205635
Pediatr Infect Dis J. 2010 Apr;29(4):289-93
pubmed: 19935447
J Mol Biol. 2009 Apr 10;387(4):899-909
pubmed: 19233207
Lancet Infect Dis. 2019 Jul;19(7):759-769
pubmed: 31196809
Semin Immunopathol. 2016 Jul;38(4):425-48
pubmed: 27116944
J Antimicrob Chemother. 2019 Aug 1;74(Suppl 4):iv39-iv47
pubmed: 31505644
J Clin Microbiol. 2017 May;55(5):1416-1425
pubmed: 28202800
Vaccines (Basel). 2021 Mar 16;9(3):
pubmed: 33809706
Microb Genom. 2021 Sep;7(9):
pubmed: 34550067
Infect Immun. 2013 Dec;81(12):4519-24
pubmed: 24082068
J R Soc Interface. 2013 Oct 16;10(89):20130786
pubmed: 24132203
PLoS Pathog. 2019 Aug 29;15(8):e1007911
pubmed: 31465516
mBio. 2014 Jul 22;5(4):e01490-14
pubmed: 25053789
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12896-12901
pubmed: 30559195
J Pediatric Infect Dis Soc. 2019 May 11;8(2):187-188
pubmed: 30496558
Microb Genom. 2019 Oct;5(10):
pubmed: 31609685
Front Cell Infect Microbiol. 2019 Jul 18;9:258
pubmed: 31380301
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
PLoS Med. 2011 Apr;8(4):e1001017
pubmed: 21483718
J Antimicrob Chemother. 2015 Mar;70(3):670-9
pubmed: 25411187
Cell Rep. 2022 Dec 13;41(11):111835
pubmed: 36516783
J Infect Dis. 2022 Aug 24;226(2):342-351
pubmed: 35481950
PLoS Biol. 2020 Oct 22;18(10):e3000878
pubmed: 33091022
Antimicrob Agents Chemother. 2003 Jul;47(7):2072-81
pubmed: 12821449
Antimicrob Agents Chemother. 2005 Jun;49(6):2561-4
pubmed: 15917574
PLoS Pathog. 2015 Jul 16;11(7):e1005034
pubmed: 26181911
Antimicrob Agents Chemother. 2005 Feb;49(2):779-80
pubmed: 15673766
Annu Rev Genet. 2015;49:577-601
pubmed: 26473380
J Infect Dev Ctries. 2012 Jun 15;6(6):516-20
pubmed: 22706195
Clin Microbiol Rev. 2016 Jul;29(3):525-52
pubmed: 27076637
Lancet. 1996 Jul 27;348(9022):271-2
pubmed: 8684225
Nat Microbiol. 2022 Nov;7(11):1791-1804
pubmed: 36216891
Cell. 2014 Apr 10;157(2):395-406
pubmed: 24725406
Can J Infect Dis Med Microbiol. 2014 Mar;25(2):e71-5
pubmed: 24855484
Expert Rev Vaccines. 2021 Jan;20(1):45-57
pubmed: 33507135
Clin Infect Dis. 2017 Nov 13;65(11):1813-1818
pubmed: 29020195
Pediatrics. 1998 Apr;101(4 Pt 1):604-11
pubmed: 9521941
J Antimicrob Chemother. 2020 Mar 1;75(3):512-520
pubmed: 31789384
Mol Microbiol. 1998 Jan;27(1):73-83
pubmed: 9466257
Antimicrob Agents Chemother. 2015;59(6):3098-108
pubmed: 25779578
J Bacteriol. 2004 Jun;186(12):3721-9
pubmed: 15175285
Genome Biol Evol. 2014 Dec 04;6(12):3281-94
pubmed: 25480686
J Infect Chemother. 2020 Jul;26(7):749-751
pubmed: 32409019
Pharmacotherapy. 2022 Dec 26;:
pubmed: 36571459
mBio. 2022 Apr 26;13(2):e0015822
pubmed: 35289642
Vaccine. 2019 Jan 7;37(2):296-305
pubmed: 30502068
J Antimicrob Chemother. 2003 Dec;52(6):944-52
pubmed: 14585861
J Med Microbiol. 2000 Dec;49(12):1057-1067
pubmed: 11129716
J Antimicrob Chemother. 2014 Jun;69(6):1501-9
pubmed: 24562614
Infect Genet Evol. 2015 Jul;33:334-42
pubmed: 25461843
Vaccine. 2011 May 17;29(22):3857-62
pubmed: 21459175
Biomed Res Int. 2019 Feb 13;2019:3427174
pubmed: 30895191
Lancet Glob Health. 2018 Jul;6(7):e744-e757
pubmed: 29903376
JAMA. 1979 Apr 20;241(16):1707-9
pubmed: 34736
Pediatrics. 1976 Sep;58(3):378-81
pubmed: 8756
J Med Microbiol. 2017 Jul;66(7):847-858
pubmed: 28650313
J Infect Dis. 2008 Apr 1;197(7):1016-27
pubmed: 18419539
Clin Vaccine Immunol. 2007 Jul;14(7):863-8
pubmed: 17494636
Am J Med. 2005 Mar;118(3):259-68
pubmed: 15745724
J Infect Chemother. 2016 Feb;22(2):72-7
pubmed: 26705748
J Clin Microbiol. 2006 Mar;44(3):743-9
pubmed: 16517849
Expert Rev Vaccines. 2017 Oct;16(10):1007-1027
pubmed: 28783380
Microbiology (Reading). 2012 Sep;158(Pt 9):2353-2362
pubmed: 22723288
Microbiol Spectr. 2019 Mar;7(2):
pubmed: 30977464
Lancet Microbe. 2022 Oct;3(10):e735-e743
pubmed: 35985351
Pediatr Infect Dis J. 2014 May;33(5):504-10
pubmed: 24670957
PLoS One. 2013;8(2):e57047
pubmed: 23437306
J Infect Dis. 2010 Jan 1;201(1):32-41
pubmed: 19947881
Pediatr Infect Dis J. 2007 Jun;26(6):468-72
pubmed: 17529860
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28971878
Am Fam Physician. 2014 Jun 15;89(12):938-41
pubmed: 25162160
Nat Genet. 2012 Jan 29;44(3):352-5
pubmed: 22286217
J Infect Dis. 2013 Feb 1;207(3):439-49
pubmed: 23175765
Emerg Infect Dis. 2018 Oct;24(10):1919-1922
pubmed: 30226184
Clin Microbiol Rev. 1990 Apr;3(2):171-96
pubmed: 2187594
J Infect Dis. 1996 Dec;174(6):1271-8
pubmed: 8940218
J Infect Dis. 2013 Jul 15;208(2):203-10
pubmed: 23559465
Mol Microbiol. 2008 Jul;69(1):245-53
pubmed: 18485065
Proc Biol Sci. 2013 Oct 02;280(1771):20131939
pubmed: 24089337
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
N Engl J Med. 2003 May 1;348(18):1737-46
pubmed: 12724479
Microbiol Res. 2023 Jan;266:127221
pubmed: 36244081
Clin Microbiol Infect. 2009 Nov;15(11):1002-7
pubmed: 19392883
Annu Rev Microbiol. 2018 Sep 8;72:521-549
pubmed: 30200849
Antimicrob Agents Chemother. 1997 Nov;41(11):2406-13
pubmed: 9371341
Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5439-44
pubmed: 24706866
Infect Immun. 1988 Aug;56(8):1890-6
pubmed: 3397179
J Infect Dis. 2020 Apr 27;221(10):1669-1676
pubmed: 31875229
mBio. 2021 May 18;12(3):
pubmed: 34006665
Nat Microbiol. 2020 Mar;5(3):473-485
pubmed: 32015499
Sci Transl Med. 2021 Aug 11;13(606):
pubmed: 34380772
Clin Infect Dis. 2000 Jan;30(1):100-21
pubmed: 10619740
Am J Respir Crit Care Med. 2013 Apr 15;187(8):855-64
pubmed: 23370916
Vaccine. 2013 Dec 16;31(52):6232-8
pubmed: 24176490
BMC Infect Dis. 2010 Apr 08;10:90
pubmed: 20377886
PLoS Genet. 2014 Aug 07;10(8):e1004547
pubmed: 25101644
mBio. 2016 Mar 22;7(2):e01792
pubmed: 27006456
PLoS Pathog. 2009 Jun;5(6):e1000476
pubmed: 19521509
Bioinformatics. 2021 Aug 25;37(16):2473-2475
pubmed: 33459763
J Infect Dis. 2010 Apr 15;201(8):1208-24
pubmed: 20199241
Lancet Glob Health. 2017 Jan;5(1):e51-e59
pubmed: 27955789
Antimicrob Agents Chemother. 2015 Jul;59(7):4339-42
pubmed: 25918135
Lancet Infect Dis. 2017 Nov;17(11):1100-1101
pubmed: 28843577
Nat Ecol Evol. 2017 Dec;1(12):1950-1960
pubmed: 29038424
Clin Infect Dis. 2011 Jul 15;53(2):137-43
pubmed: 21690620
Int J Infect Dis. 2021 Apr;105:695-701
pubmed: 33676003
Front Microbiol. 2015 Feb 09;6:26
pubmed: 25709602
J Antimicrob Chemother. 2002 Jun;49(6):893-5
pubmed: 12039880
N Engl J Med. 2006 Apr 6;354(14):1455-63
pubmed: 16598044
Rev Argent Microbiol. 2021 Jul-Sep;53(3):266-271
pubmed: 33875295
PLoS Pathog. 2007 Nov;3(11):e168
pubmed: 18020702
Clin Infect Dis. 2017 Sep 15;65(6):990-998
pubmed: 28903506
mSphere. 2020 Jan 29;5(1):
pubmed: 31996416
Clin Infect Dis. 2002 Jul 15;35(2):205-8
pubmed: 12087529
Antimicrob Agents Chemother. 2007 Nov;51(11):3977-82
pubmed: 17709460
Emerg Infect Dis. 2003 Jul;9(7):833-7
pubmed: 12890324
Nat Genet. 2014 Mar;46(3):305-309
pubmed: 24509479
Nat Genet. 2013 Jun;45(6):656-63
pubmed: 23644493
Elife. 2021 Jul 14;10:
pubmed: 34259624
Am J Ther. 2017 May;24(3):e361-e369
pubmed: 28430673
Clin Microbiol Infect. 2023 Jan;29(1):70-76
pubmed: 35934196
Lancet Infect Dis. 2008 Dec;8(12):785-95
pubmed: 19022193
Antimicrob Agents Chemother. 2011 Jan;55(1):190-6
pubmed: 20937787

Auteurs

Cydney N Johnson (CN)

Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Shyra Wilde (S)

Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Elaine Tuomanen (E)

Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: elaine.tuomanen@stjude.org.

Jason W Rosch (JW)

Department of Host-Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH